Sodium fluoride oral rinse recalled for manufacturing deviations
Activator Concentrate, a sodium fluoride oral rinse manufactured by Ecometics, Inc., was voluntarily recalled due to manufacturing practice deviations. The recall affected 34,320 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for manufacturing practice deviations with no reported illnesses or injuries. This is a voluntary, precautionary recall.
Plain-English summary
Activator Concentrate is a liquid oral rinse containing sodium fluoride (0.96%), supplied in 1 fl. oz. plastic bottles, manufactured by Ecometics, Inc., for All USA Direct LLC. The recalled product is identified by lot number 2E055A with an expiration date of February 2025.
The manufacturer initiated a voluntary recall due to manufacturing practice deviations, affecting 34,320 bottles distributed nationwide within the United States. The FDA classified this as a Class II recall.
The recall was initiated on February 24, 2023, and was completed on June 21, 2023.
The recalled product
- Product
- Activator Concentrate (sodium fluoride 0.96% in Activator) 1 fl. Oz, liquid oral rinse plastic bottles, Manufactured for: All USA Direct LLC, Broadview, IL 60155
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Oral Rinse
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2E055A
- Exp. Date Feb-2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27